{"id":159831,"date":"2023-09-21T06:49:44","date_gmt":"2023-09-21T01:19:44","guid":{"rendered":"https:\/\/dripp.zone\/news\/?p=159831"},"modified":"2023-09-21T06:49:44","modified_gmt":"2023-09-21T01:19:44","slug":"brain-implant-testing-neuralink-begins-recruiting-for-human-thought-reading-trials-crypto-news","status":"publish","type":"post","link":"https:\/\/dripp.zone\/news\/brain-implant-testing-neuralink-begins-recruiting-for-human-thought-reading-trials-crypto-news\/","title":{"rendered":"Brain Implant Testing: Neuralink Begins Recruiting for Human Thought-Reading Trials &#8211; Crypto News"},"content":{"rendered":"<p><\/p>\n<div style=\"position:relative;overflow:visible;font-size:1.2em;line-height:1.58\">\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">After getting the green light from the FDA, Elon Musk\u2019s Neuralink is ready to begin testing its controversial brain chip implants in paralyzed human volunteers. The company announced in an official <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/neuralink.com\/blog\/first-clinical-trial-open-for-recruitment\/\" class=\"sc-adb616fe-0 ePvUAp\">blog post<\/a> that it is now recruiting participants for a clinical trial to evaluate the safety and functionality of its technology.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">&#8220;The PRIME Study is being conducted under the investigational device exemption (IDE) awarded by the FDA in May 2023 and represents an important step in our mission to create a generalized brain interface to restore autonomy to those with unmet medical needs,&#8221; the company wrote. \u201cThe initial goal of our BCI is to grant people the ability to control a computer cursor or keyboard using their thoughts alone.\u201d<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">To achieve its goal, tiny flexible threads with electrodes would be surgically embedded in the region of the brain that controls movement.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">&#8220;During the study, the R1 Robot will be used to surgically place the N1 Implant in a region of the brain that controls movement intention,\u201d the company said. \u201cParticipants will be asked to use the N1 Implant and N1 User App to control a computer and provide feedback about the system.\u201d<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Once implanted, Neuralink claims its device could potentially read a user&#8217;s intended hand and finger movements and translate them into commands to control external devices.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">The N1 Implant is a chip that records neural activity. It measures around 8mm in diameter, but each of its 1,024 electrodes is thinner than a human hair, according to the company.<\/p>\n<figure class=\"w-full max-w-full mt-4 overflow-hidden\"><span style=\"overflow:hidden;width:initial;height:initial;background:none;border:0;margin:0;padding:0;position:relative\"><span style=\"width:initial;height:initial;background:none;border:0;margin:0;padding:0;padding-top:56.25%\" \/><img decoding=\"async\" alt=\"Exploded view of the N1 chip. Source: Neuralink\" loading=\"lazy\" data-nimg=\"responsive\" style=\"position:absolute;top:0;left:0;bottom:0;right:0;padding:0;border:none;margin:auto;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain\" class=\"absolute inset-0 box-border p-0 border-0 m-auto block w-0 h-0 min-w-full max-w-full min-h-full max-h-full object-contain\" src=\"https:\/\/img.decrypt.co\/insecure\/rs:fit:1536:0:0:0\/plain\/https:\/\/cdn.decrypt.co\/wp-content\/uploads\/2023\/09\/Neuralink-chip.webp@webp\" \/><\/span><figcaption class=\"m-0 text-left gg-dark:text-neutral-200 scene:font-itc-avant-garde-gothic-pro scene:text-neutral-700 scene:font-light scene:mt-1\">Exploded view of Neuralink&#8217;s implant with the N1 chip. Source: Neuralink<\/figcaption><\/figure>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">This highly invasive approach is not without risks, but other researchers have had recent breakthroughs in restoring mobility to paralyzed patients using less intrusive methods. As <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/decrypt.co\/151068\/ai-brain-implant-paralyzed-quadriplegic-move-feel-touch\" class=\"sc-adb616fe-0 ePvUAp\">previously reported<\/a> by <i>Decrypt<\/i>, quadriplegic Keith Thomas regained the ability to move his arm simply by thinking about it after scientists at Northwell Health implanted sensors on the surface of his brain.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">If proven safe and effective, Neuralink\u2019s brain chips could offer new independence to those suffering from paralysis due to spinal cord injuries or conditions like ALS. However, the technology also raises concerns about the ethics of implants that can literally read people&#8217;s thoughts.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Neuralink\u2019s announcement follows a controversial history of animal testing. As detailed in a Reuters report, the company has been accused of botched experiments that resulted in over <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.reuters.com\/technology\/musks-neuralink-faces-federal-probe-employee-backlash-over-animal-tests-2022-12-05\/\" class=\"sc-adb616fe-0 ePvUAp\">1500 animal deaths<\/a>.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Those willing to test the device will receive compensation for \u201c study-related costs\u201d during the course of the six years that the study will last.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">The experiment, called &#8220;The PRIME Study\u201d (short for Precise Robotically Implanted Brain-Computer Interface), has been approved to start at a single, undisclosed hospital site for now. But Neuralink has grand ambitions for its tech, recently raising $280 million in funding, as <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/decrypt.co\/151652\/neuralink-elon-musk-brain-interface-funding-peter-thiel\" class=\"sc-adb616fe-0 ePvUAp\">reported previously<\/a> by <i>Decrypt<\/i>.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Neuralink proposes a future where AI-powered, thought-reading chips are commonplace and augment human capabilities.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Still, many regulatory and ethical hurdles remain before tech billionaire Elon Musk\u2019s vision becomes reality. While advances like Neuralink\u2019s hold promise for patients with limited mobility, the line between treatment and human enhancement could become blurred.<\/p>\n<div class=\"my-4 border-b border-decryptGridline\">\n<div class=\"text-left p-8 md:py-12 md:px-12 max-w-prose relative\"><span class=\"border-t-4 border-l-4 w-4 h-4 md:border-t-[6px] md:border-l-[6px] md:w-6 md:h-6 border-decryptPurple dark:border-decryptNeon gg-dark:border-cc-pink-2 absolute top-4 left-4 md:top-6 md:left-6\" \/><span class=\"border-t-4 border-l-4 w-4 h-4 md:border-t-[6px] md:border-l-[6px] md:w-6 md:h-6 border-decryptPurple dark:border-decryptNeon gg-dark:border-cc-pink-2 absolute rotate-180 bottom-4 right-4 md:bottom-6 md:right-6\" \/><\/p>\n<h3 class=\"font-akzidenz-grotesk font-bold text-xl md:text-3xl mb-6 md:text-center gg-dark:text-white\">Stay on top of crypto news, get daily updates in your inbox.<\/h3>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>After getting the green light from the FDA, Elon Musk\u2019s Neuralink is ready to begin testing its controversial brain chip implants in paralyzed human volunteers. The company announced in an official blog post that it is now recruiting participants for a clinical trial to evaluate the safety and functionality of its technology. &#8220;The PRIME Study [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":159832,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[230,225,221,227,226,228,229,60,223,224,222],"class_list":["post-159831","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cryptocurrency","tag-brave","tag-coinbase","tag-crypto","tag-decentralised","tag-decentralized","tag-decentralized-exchange","tag-erc-20","tag-featured","tag-meme-coin","tag-robinhood","tag-solana"],"_links":{"self":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/159831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/comments?post=159831"}],"version-history":[{"count":2,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/159831\/revisions"}],"predecessor-version":[{"id":159834,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/159831\/revisions\/159834"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/media\/159832"}],"wp:attachment":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/media?parent=159831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/categories?post=159831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/tags?post=159831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}